調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021

糖鎖生物学グライコミクス/グリコバイオロジーの世界市場予測（～2021）：製品別（酵素（グリコシルトランスフェラーゼ、グリコシダーゼ）、機器別（高速液体クロマトグラフィー(HPLS)、質量分析、マトリックス支援レーザー脱離イオン化-飛行時間型質量分析(MALDITOF)）、キットおよび試薬別（糖タンパク質））、用途別（診断、創薬、腫瘍学）、エンドユーザー別

◆タイトル：Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021
◆商品コード：MAM-BT-2776
◆調査・発行会社：MarketsandMarkets
◆発行日：2017年1月30日
◆ページ数：160
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：バイオ技術
◆販売価格オプション（消費税別）

Single User（1名利用）	USD5,650 ⇒換算￥610,200	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥718,200	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥880,200	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、糖鎖生物学グライコミクス/グリコバイオロジーの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、用途別分析、需要先別分析、地域別分析、糖鎖生物学グライコミクス/グリコバイオロジーの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global glycomics/glycobiology market is poised to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%. The glycomics/glycobiology market is segmented on the basis of product, application, end user, and region.
Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of the global glycomics/glycobiology market.

On the basis of product, the market is segmented into enzymes, instruments, kits, and reagents. The enzymes segment is projected to grow at the highest CAGR during the
forecast period. This growth is mainly attributed to their consumable nature and wide applications in a variety of R&D and drug discovery procedures. The enzymes segment is further divided into glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, and other enzymes.
On the basis of application, the market is segmented into diagnostics, drug discovery & development, oncology, immunology, and other applications. In 2016, the drug discovery and development segment is expected to account for the largest share of the market. This growth can be attributed to increase in R&D activities for the development of novel drugs and therapies.

On the basis of region, the market is segmented into North America, Asia, Europe, and RoW. The Asian market is estimated to grow at the highest CAGR during the forecast period. This growth is mainly attributed to the increasing commercialization of R&D by pharmaceutical and biotechnology companies, growing demand for personalized medicine, and rising importance of companion diagnostics.

Apart from comprehensive regional and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on the key players in the glycomics/glycobiology market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, regional focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms garner a higher market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product portfolios of the top players in the glycomics/glycobiology market. The report analyzes the glycomics/glycobiology by product, application, end user, and region
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the glycomics/glycobiology market
• Competitive Assessment: In-depth assessment of the market strategies, regional and business segments, and product portfolios of the leading players in the glycomics/glycobiology market
• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various glycomics/glycobiology offerings across regions
• Market Diversification: Exhaustive information about new products and services, untapped regions, recent developments, and investments in the glycomics/glycobiology market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKETS DEFINITION 13
1.3 MARKETS COVERED 14
1.3.1 YEARS CONSIDERED FOR THE STUDY 14
1.4 CURRENCY 15
1.5 MARKET SCOPE 15
1.6 MARKET STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 MARKET SIZE ESTIMATION 17
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 20
2.3 MARKET SHARE ESTIMATION 21
2.3.1 KEY DATA FROM SECONDARY SOURCES 21
2.3.2 KEY DATA FROM PRIMARY SOURCES 22
2.3.3 ASSUMPTIONS FOR THE STUDY 22
3 EXECUTIVE SUMMARY 23
4 PREMIUM INSIGHTS 28
4.1 GLYCOMICS: MARKET OVERVIEW (2016-2021) 28
4.2 GEOGRAPHIC ANALYSIS: GLYCOMICS MARKET, BY PRODUCT 29
4.3 LIFE CYCLE ANALYSIS, BY REGION 30
5 MARKET OVERVIEW 31
5.1 INTRODUCTION 32
5.2 MARKET DYNAMICS 32
5.2.1 DRIVERS 33
5.2.1.1 Increase in Funding for Proteomics and Glycomics Research, Growing R&D Expenditure 33
5.2.1.1 Growth of the Proteomics Market 33
5.2.1.2 Technological Advancements in Glycomics Instrumentation 34
5.2.2 RESTRAINTS 34
5.2.2.1 High Degree of Consolidation Hinders Entry of New Players to the Market 34
5.2.2.2 Stringent Regulatory Frameworks and Time-consuming Approval Processes 34

5.2.3 OPPORTUNITIES 35
5.2.3.1 Increased Use of Personalized Medicine 35
5.2.3.2 Biomarker Identification 35
5.2.3.3 Developing Countries and Emerging Markets 36
5.2.4 CHALLENGES 36
5.2.4.1 High Costs of Tools & Instruments and Their Maintenance 36
6 GLYCOMICS MARKET, BY PRODUCT 37
6.1 INTRODUCTION 38
6.2 ENZYMES 39
6.2.1 GLYCOSIDASES 40
6.2.2 GLYCOSYLTRANSFERASES 41
6.2.3 NEURAMINIDASES 41
6.2.4 SIALYLTRANSFERASES 42
6.2.5 OTHER GLYCOMICS ENZYMES 43
6.3 INSTRUMENTS 44
6.3.1 ANTIBODY ARRAYS 45
6.3.2 HPLC 46
6.3.3 LECTIN ARRAYS 47
6.3.4 MALDI-TOF 47
6.3.5 MASS SPECTROMETERS 48
6.3.6 OTHER GLYCOMICS INSTRUMENTS 49
6.4 KITS 50
6.4.1 GLYCAN LABELING KITS 51
6.4.2 GLYCAN PURIFICATION KITS 52
6.4.3 GLYCAN RELEASE KITS 52
6.4.4 OTHER GLYCOMICS KITS 53
6.5 REAGENTS 54
6.5.1 GLYCOPROTEINS 55
6.5.2 MONOSACCHARIDES 56
6.5.3 OLIGOSACCHARIDES 56
6.5.4 OTHER REAGENTS 57
7 GLYCOMICS MARKET, BY APPLICATION 58
7.1 INTRODUCTION 59
7.2 DIAGNOSTICS 60
7.3 DRUG DISCOVERY & DEVELOPMENT 61
7.4 ONCOLOGY 62
7.5 IMMUNOLOGY 64
7.6 OTHER APPLICATIONS 65

8 GLYCOMICS MARKET, BY END USER 67
8.1 INTRODUCTION 68
8.2 ACADEMIC RESEARCH INSTITUTES 69
8.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 70
8.4 CONTRACT RESEARCH ORGANIZATIONS 71
9 GLYCOMICS MARKET, BY REGION 73
9.1 INTRODUCTION 74
9.2 NORTH AMERICA 75
9.2.1 U.S. 80
9.2.2 CANADA 81
9.3 EUROPE 82
9.3.1 GERMANY 86
9.3.2 FRANCE 88
9.3.3 U.K. 89
9.3.4 ITALY 89
9.3.5 SPAIN 91
9.3.6 ROE 92
9.4 ASIA 93
9.4.1 CHINA 99
9.4.2 JAPAN 100
9.4.3 INDIA 101
9.4.4 REST OF ASIA 101
9.5 REST OF THE WORLD (ROW) 102
9.5.1 SOUTH AMERICA 106
9.5.2 MIDDLE EAST AND AFRICA 107
9.5.3 PACIFIC AND OCEANIA 108
10 COMPETITIVE LANDSCAPE 109
10.1 OVERVIEW 109
10.2 MARKET SHARE ANALYSIS 110
10.2.1 GLYCOMICS ENZYMES, KITS, AND REGENTS 110
10.2.2 GLYCOMICS INSTRUMENTS 111
10.3 COMPETITIVE SITUATION AND TRENDS 113
10.3.1 PRODUCT LAUNCHES 114
10.3.2 EXPANSIONS 115
10.3.3 AGREEMENTS 116
10.3.4 ACQUISITIONS, COLLABORATIONS, APPROVALS, AND OTHERS 117

11 COMPANY PROFILES 118
(Overview, Products and Services, Financials, Strategy & Development)*
11.1 INTRODUCTION 118
11.2 MERCK KGAA 119
11.3 TAKARA BIO, INC. 122
11.4 SHIMADZU CORPORATION 124
11.5 BRUKER CORPORATION 128
11.6 WATERS CORPORATION 132
11.7 NEW ENGLAND BIOLABS INC. 136
11.8 AGILENT TECHNOLOGIES, INC. 138
11.9 DANAHER CORPORATION 141
11.10 PROZYME, INC. 143
11.11 THERMO FISHER SCIENTIFIC, INC. 146
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
12 APPENDIX 149
12.1 INSIGHTS OF INDUSTRY EXPERTS 149
12.2 DISCUSSION GUIDE 150
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 153
12.4 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 155
12.5 AVAILABLE CUSTOMIZATIONS 156
12.6 RELATED REPORTS 157
12.7 AUTHOR DETAILS 158

LIST OF TABLES

TABLE 1 GLYCOMICS MARKET SUMMARY 23
TABLE 2 GLYCOMICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 38
TABLE 3 GLYCOMICS ENZYMES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 39
TABLE 4 GLYCOMICS ENZYMES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 40
TABLE 5 GLYCOSIDASES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 40
TABLE 6 GLYCOSYLTRANSFERASES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 41
TABLE 7 NEURAMINIDASES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 42
TABLE 8 SIALYLTRANSFERASES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 42
TABLE 9 OTHER GLYCOMICS ENZYMES MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 43
TABLE 10 GLYCOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 44
TABLE 11 GLYCOMICS INSTRUMENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 45
TABLE 12 ANTIBODY ARRAYS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 45
TABLE 13 HPLC MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 46
TABLE 14 LECTIN ARRAYS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 47
TABLE 15 MALDI-TOF MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 48
TABLE 16 MASS SPECTROMETRY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 48
TABLE 17 OTHER GLYCOMICS INSTRUMENTS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 49
TABLE 18 GLYCOMICS KITS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 50
TABLE 19 GLYCOMICS KITS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 51
TABLE 20 GLYCAN LABELING KITS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 51
TABLE 21 GLYCAN PURIFICATION KITS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 52
TABLE 22 GLYCAN RELEASE KITS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 53
TABLE 23 OTHER GLYCOMICS KITS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 53
TABLE 24 GLYCOMICS REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 54
TABLE 25 GLYCOMICS REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 55
TABLE 26 GLYCOPROTEINS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 55
TABLE 27 MONOSACCHARIDES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 56
TABLE 28 OLIGOSACCHARIDES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 57
TABLE 29 OTHER REAGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 57
TABLE 30 GLYCOMICS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 59
TABLE 31 GLYCOMICS MARKET SIZE FOR DIAGNOSTICS, BY REGION,
2014–2021 (USD MILLION) 60
TABLE 32 GLYCOMICS MARKET SIZE FOR DRUG DISCOVERY AND DEVELOPMENT,
BY REGION, 2014–2021 (USD MILLION) 62
TABLE 33 GLYCOMICS MARKET SIZE FOR ONCOLOGY, BY REGION,
2014–2021 (USD MILLION) 64
TABLE 34 GLYCOMICS MARKET SIZE FOR IMMUNOLOGY, BY REGION,
2014–2021 (USD MILLION) 65
TABLE 35 GLYCOMICS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION,
2014–2021 (USD MILLION) 66
TABLE 36 GLYCOMICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 68
TABLE 37 GLYCOMICS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2014–2021 (USD MILLION) 70
TABLE 38 GLYCOMICS MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2014–2021 (USD MILLION) 71
TABLE 39 GLYCOMICS MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS,
BY REGION, 2014–2021 (USD MILLION) 72
TABLE 40 GLYCOMICS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 75
TABLE 41 NORTH AMERICA: GLYCOMICS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 77
TABLE 42 NORTH AMERICA: GLYCOMICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 77
TABLE 43 NORTH AMERICA: GLYCOMICS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 77
TABLE 44 NORTH AMERICA: GLYCOMICS ENZYMES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 78
TABLE 45 NORTH AMERICA: GLYCOMICS INSTRUMENTS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 78
TABLE 46 NORTH AMERICA: GLYCOMICS KITS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 79
TABLE 47 NORTH AMERICA: GLYCOMICS REAGENTS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 79
TABLE 48 NORTH AMERICA: GLYCOMICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 80
TABLE 49 U.S.: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 81
TABLE 50 CANADA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 82
TABLE 51 EUROPE: GLYCOMICS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 83
TABLE 52 EUROPE: GLYCOMICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 83
TABLE 53 EUROPE: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 84
TABLE 54 EUROPE: GLYCOMICS ENZYMES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 84
TABLE 55 EUROPE: GLYCOMICS INSTRUMENTS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 85
TABLE 56 EUROPE: GLYCOMICS KITS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 85
TABLE 57 EUROPE: GLYCOMICS REAGENTS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 86
TABLE 58 EUROPE: GLYCOMICS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 86
TABLE 59 GERMANY: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 87
TABLE 60 FRANCE: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 88
TABLE 61 U.K.: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 89
TABLE 62 ITALY: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 90
TABLE 63 SPAIN: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 91
TABLE 64 ROE: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 92
TABLE 65 ASIA: GLYCOMICS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 95
TABLE 66 ASIA: GLYCOMICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 95
TABLE 67 ASIA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 96
TABLE 68 ASIA: GLYCOMICS ENZYMES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 96
TABLE 69 ASIA: GLYCOMICS INSTRUMENTS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 97
TABLE 70 ASIA: GLYCOMICS KITS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 97
TABLE 71 ASIA: GLYCOMICS REAGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 98
TABLE 72 ASIA: GLYCOMICS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 98
TABLE 73 CHINA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 99
TABLE 74 JAPAN: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 100
TABLE 75 INDIA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 101
TABLE 76 ROA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 102
TABLE 77 ROW: GLYCOMICS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 103
TABLE 78 ROW: GLYCOMICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 103
TABLE 79 ROW: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 103
TABLE 80 ROW: GLYCOMICS ENZYMES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 104
TABLE 81 ROW: GLYCOMICS INSTRUMENTS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 104
TABLE 82 ROW: GLYCOMICS KITS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 105
TABLE 83 ROW: GLYCOMICS REAGENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 105
TABLE 84 ROW: GLYCOMICS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 106
TABLE 85 SOUTH AMERICA: GLYCOMICS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 107
TABLE 86 MIDDLE EAST AND AFRICA: GLYCOMICS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 108
TABLE 87 PACIFIC AND OCEANIA: GLYCOMICS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 108
TABLE 88 PRODUCT LAUNCHES, 2013–2016 114
TABLE 89 EXPANSIONS, 2013-2016 115
TABLE 90 AGREEMENTS, 2013–2016 116
TABLE 91 ACQUISITIONS, COLLABORATIONS, APPROVALS, AND OTHERS, 2013–2016 117

LIST OF FIGURES

FIGURE 1 GLOBAL GLYCOMICS MARKET 14
FIGURE 2 RESEARCH METHODOLOGY 16
FIGURE 3 BOTTOM-UP APPROACH 18
FIGURE 4 TOP-DOWN APPROACH 18
FIGURE 5 BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
& REGION 19
FIGURE 6 DATA TRIANGULATION METHODOLOGY 20
FIGURE 7 ENZYMES TO REGISTER THE HIGHEST CAGR BETWEEN 2016 & 2021 24
FIGURE 8 GLYCOSIDASES TO DOMINATE THE GLYCOMICS ENZYMES MARKET IN 2016 25
FIGURE 9 MASS SPECTROMETRY TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 25
FIGURE 10 GLYCAN RELEASE KITS TO DOMINATE THE GLYCOMICS KITS MARKET IN 2016 26
FIGURE 11 OLIGOSACCHARIDES TO COMMAND THE LARGEST SHARE OF THE GLYCOMICS REAGENTS MARKET IN 2016 26
FIGURE 12 INCREASING FUNDING IN GLYCOMICS AND PROTEOMICS RESEARCH TO DRIVE THE NORTH AMERICAN GLYCOMICS MARKET 27
FIGURE 13 INCREASING FUNDING FOR PROTEOMICS & GLYCOMICS RESEARCH IS AN IMPORTANT GROWTH DRIVER FOR THE GLYCOMICS MARKET 28
FIGURE 14 ENZYMES TO ACCOUNT FOR THE LARGEST PRODUCT SEGMENT OF THE GLYCOMICS MARKET IN 2016 29
FIGURE 15 ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 30
FIGURE 16 ASIA HOLDS LUCRATIVE GROWTH OPPORTUNITIES FOR GLYCOMICS PRODUCTS DURING THE FORECAST PERIOD 30
FIGURE 17 INCREASING GOVERNMENT AND PRIVATE FUNDING FOR PROTEOMICS AND GLYCOMICS RESEARCH TO DRIVE THE DEMAND FOR GLYCOMICS PRODUCTS 32
FIGURE 18 GLYCOMICS MARKET IN ASIA TO REGISTER HIGHEST GROWTH DURING
THE FORECAST 74
FIGURE 19 NORTH AMERICA: GLYCOMICS MARKET SNAPSHOT 76
FIGURE 20 ASIA: GLYCOMICS MARKET SNAPSHOT 94
FIGURE 21 KEY DEVELOPMENTS IN THE GLOBAL GLYCOMICS MARKET, 2013–2016 109
FIGURE 22 GLOBAL GLYCOMICS ENZYMES, KITS, AND REAGENTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015 110
FIGURE 23 BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES IS THE KEY STRATEGY ADOPTED BY PLAYERS IN THE GLYCOMICS MARKET BETWEEN 2013 & 2016 113
FIGURE 24 GEOGRAPHIC REVENUE MIX OF TOP 5 MARKET PLAYERS 118
FIGURE 25 MERCK KGAA: COMPANY SNAPSHOT (2015) 119
FIGURE 26 TAKARA BIO, INC.: COMPANY SNAPSHOT (2015) 122
FIGURE 27 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2015) 124
FIGURE 28 BRUKER CORPORATION: COMPANY SNAPSHOT (2015) 128
FIGURE 29 WATERS CORPORATION: COMPANY SNAPSHOT (2015) 132
FIGURE 30 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2015) 138
FIGURE 31 DANAHER CORPORATION COMPANY SNAPSHOT (2015) 141
FIGURE 32 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2015) 146

★調査レポート[糖鎖生物学グライコミクス/グリコバイオロジーの世界市場予測（～2021）：製品別（酵素（グリコシルトランスフェラーゼ、グリコシダーゼ）、機器別（高速液体クロマトグラフィー(HPLS)、質量分析、マトリックス支援レーザー脱離イオン化-飛行時間型質量分析(MALDITOF)）、キットおよび試薬別（糖タンパク質））、用途別（診断、創薬、腫瘍学）、エンドユーザー別] ( Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021 / MAM-BT-2776) 販売に関する免責事項

[糖鎖生物学グライコミクス/グリコバイオロジーの世界市場予測（～2021）：製品別（酵素（グリコシルトランスフェラーゼ、グリコシダーゼ）、機器別（高速液体クロマトグラフィー(HPLS)、質量分析、マトリックス支援レーザー脱離イオン化-飛行時間型質量分析(MALDITOF)）、キットおよび試薬別（糖タンパク質））、用途別（診断、創薬、腫瘍学）、エンドユーザー別] ( Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021 / MAM-BT-2776) についてEメールでお問い合わせ

◆関連調査資料◆

RSV診断の世界市場予測（～2022年）：キット、アッセイ、装置、方法、エンドユーザー
MAM-MD-6013 / MarketsandMarkets / 2018年2月16日 / MarketsandMarketsが発行した当調査レポートでは、RSV診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、方式別分析、需要先別分析、地域別分析、RSV診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global RSV diagnostics market projected to grow at a CAGR of 10.1% during the forecast period”The RSV diagnostics market is expected to reach USD 929.2 million by 2022 from USD 574.3 million in 2017, at a CAGR of 10.1%. Factors driving the growth of this market include rising burden of RSV infections, growing demand for molecular diagnostic tests for the diagnosis of RSV infections, increasing adoption of point-of-care testing for RSV diagnosis and increasing approval of RSV diagnostic kits and assays. On the other hand, the development of RSV vaccine is expected to emerge as a biggest threat which...

組織診断の世界市場予測（～2022年）：消耗品、装置、技術、疾患、エンドユーザー
MAM-MD-2349 / MarketsandMarkets / 2017年11月9日 / MarketsandMarketsが発行した当調査レポートでは、組織診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、技術別分析、疾患別分析、需要先別分析、組織診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Global tissue diagnostics market projected to grow at a CAGR of 6.9% during the forecast period”The tissue diagnostics market is expected to reach USD 5.14 billion by 2022 from USD 3.68 billion in 2017, at a CAGR of 6.9%. Factors driving the growth of this market include the rising incidence of cancer, growing healthcare expenditure, improving infrastructure for cancer diagnosis, and technological advancements in tissue diagnostics. On the other hand, complex regulatory frameworks that delay the approval of new diagnostic products and lack of infrastructure are expected to challenge market growth to a certain extent. “The breast cancer segment is...

感染症診断の世界市場予測（～2022年）：製品・サービス、疾患種類、技術、エンドユーザー
MAM-MD-3088 / MarketsandMarkets / 2018年4月16日 / MarketsandMarketsが発行した当調査レポートでは、感染症診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品・サービス別分析、疾患種類別分析、技術別分析、エンドユーザー別分析、感染症診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global infectious disease diagnostics market is projected to grow at a CAGR of 5.6%.”The global infectious disease diagnostics market is expected to reach USD 19.35 billion by 2022 from USD 14.73 billion in 2017, at a CAGR of 5.6%. Growth in this market can primarily be attributed to factors such as increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics. However, inadequate reimbursement and rising healthcare cost limiting usage of novel diagnostic technologies are expected to restrain the growth of this market...

フローサイトメトリーの世界市場予測（～2022年）：技術、製品・サービス、用途、エンドユーザー
MAM-BT-6015 / MarketsandMarkets / 2018年2月20日 / MarketsandMarketsが発行した当調査レポートでは、フローサイトメトリーの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術別分析、製品・サービス別分析、需要先別分析、地域別分析、フローサイトメトリーの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global flow cytometry market is projected to grow at a CAGR of 7.8%.”The global flow cytometry market is projected to reach USD 4.79 billion by 2022 from USD 3.29 billion in 2017, growing at a CAGR of 7.8% from 2017 to 2022. The key factors driving the growth of this market include the continuous technological advancements in the field of flow cytometry, increasing incidence and prevalence of target diseases (such as HIV/AIDS and cancer), and growing adoption of flow cytometry in advanced research activities and clinical trials. However, factors such as the high cost of flow cytometry instruments and...

ラベルフリー検出の世界市場予測（～2022年）：技術（表面プラズモン共鳴法、バイオレイヤー干渉法）、製品、用途、エンドユーザー
BT-2455 / MarketsandMarkets / 2017年10月11日 / MarketsandMarketsが発行した当調査レポートでは、ラベルフリー検出の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術別分析、製品別分析、用途別分析、需要先別分析、ラベルフリー検出の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global label-free detection market is expected to reach USD 1,311.2 Million by 2022 from USD 872.0 Million in 2017, at a CAGR of 8.5%. A number of factors such as increasing number of genomics research activities for studying diseases, advances in label-free detection techniques, growing awareness and demand for use of biosensors in biomolecular interaction studies, and increasing expenditure on drug discovery and development by private and public organizations are expected to drive the growth of this market. The global label-free detection market is segmented by product, technology, application, end user, and region. By product, the market is segmented...

感染予防の世界市場予測（～2022年）：消毒製品、殺菌製品、エンドユーザー、地域別分析
MAM-MD-3503 / MarketsandMarkets / 2017年12月19日 / MarketsandMarketsが発行した当調査レポートでは、感染予防の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、消毒製品別分析、殺菌製品別分析、需要先別分析、地域別分析、感染予防の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global infection market is projected to reach USD 21.06 Billion by 2022 from USD 15.35 Billion in 2017, at a CAGR of 6.5% during the forecast period. The growth of the market can be attributed to the increasing demand of disinfection and sterilization products and services among pharmaceutical companies, hospitals, and medical device manufacturers; increasing prevalence of hospital-acquired infections; growth in the number of surgical procedures; and rising focus on food sterilization and disinfection. Also, factors such as the growth in the medical devices market, emerging markets, and the rising importance of single-use medical nonwovens and medical devices are...

医療向け分析検査サービスの世界市場予測（～2023年）：種類、エンドユーザー、地域別分析
AST-4341 / MarketsandMarkets / 2018年3月20日 / MarketsandMarketsが発行した当調査レポートでは、医療向け分析検査サービスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、種類別分析、需要先別分析、地域別分析、医療向け分析検査サービスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global healthcare analytical testing services market projected to grow at a CAGR of 11.7%.”The healthcare analytical testing services market is expected to reach USD 5.97 billion by 2023 from an estimated USD 3.43 billion in 2018, at a CAGR of 11.7%. The shift of focus towards analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical companies, increasing acceptance of the QbD approach in pharma research/manufacturing, and adoption of FTE contracts in R&D outsourcing are the major factors driving the growth of the healthcare analytical testing services market. However, factors such as the pricing pressure faced...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆